Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Schulz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Stem Cells International|June 14, 2021
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer's DiseaseJoseph M Schulz
European Journal of Medicinal Chemistry|June 4, 2026
PyMACS: A python-based automation suite for GROMACS molecular dynamics setup, simulation, and analysisJoseph M Schulz, Robert C Reynolds, Stephan C Schürer
Research Square|July 9, 2025
Benchmarking the Builders: A Comparative Analysis of PRosettaC and AlphaFold3 for Predicting PROTAC Ternary ComplexesJoseph M Schulz, Sarah I Schürer, Robert C Reynolds, et al.
Scientific Reports|October 29, 2025
PRosettaC outperforms AlphaFold3 for modeling PROTAC ternary complexesJoseph M Schulz, Sarah I Schürer, Robert C Reynolds, et al.
Journal of Natural Products|March 26, 2019
Concise Modular Synthesis of Thalassotalic Acids A-CJoseph M Schulz, Hunter T Lanovoi, Amanda M Ames, et al.
Drug Discovery Today|November 29, 2023
Targeted degrader technologies as prospective SARS-CoV-2 therapiesRabia Khurshid, Joseph M Schulz, Jiaming Hu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Stem Cells International|June 14, 2021
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer's DiseaseJoseph M Schulz
European Journal of Medicinal Chemistry|June 4, 2026
PyMACS: A python-based automation suite for GROMACS molecular dynamics setup, simulation, and analysisJoseph M Schulz, Robert C Reynolds, Stephan C Schürer
Research Square|July 9, 2025
Benchmarking the Builders: A Comparative Analysis of PRosettaC and AlphaFold3 for Predicting PROTAC Ternary ComplexesJoseph M Schulz, Sarah I Schürer, Robert C Reynolds, et al.
Scientific Reports|October 29, 2025
PRosettaC outperforms AlphaFold3 for modeling PROTAC ternary complexesJoseph M Schulz, Sarah I Schürer, Robert C Reynolds, et al.
Journal of Natural Products|March 26, 2019
Concise Modular Synthesis of Thalassotalic Acids A-CJoseph M Schulz, Hunter T Lanovoi, Amanda M Ames, et al.
Drug Discovery Today|November 29, 2023
Targeted degrader technologies as prospective SARS-CoV-2 therapiesRabia Khurshid, Joseph M Schulz, Jiaming Hu, et al.
Pageof 1